key: cord-0040089-o5jk0eia
authors: March, Philip A.
title: Diseases of the Brain and Cranial Nerves
date: 2009-05-15
journal: Saunders Manual of Small Animal Practice
DOI: 10.1016/b0-72-160422-6/50128-5
sha: 5108446cdab4088d0f6d30d4f775fd66c2e91517
doc_id: 40089
cord_uid: o5jk0eia

nan

M The brain may be anatomically and functionally divided into three major compartments, the brain stem, cerebellum, and cerebrum. Cranial nerves have their cell bodies within the brain, but most of their nerve fibers course outside the brain. Diseases of the brain and cranial nerves may be neoplastic, infectious, idiopathic, vascular, traumatic, metabolic, toxic, congenital, or degenerative in origin. These disorders may result in dysfunction of a focal, regionally specific brain area or may produce more diffuse or multifocal deficits. Because many different diseases can affect similar areas causing very similar clinical signs, the first portion of this chapter discusses clinical signs of lesions in each brain region. The remainder of the chapter discusses important brain diseases within each etiologic category. Diagnosis of neurologic disease is discussed in Chapter 125, and management of seizures is discussed in Chapter 127.

Refer also to Chapter 125.

• The brain stem contains the midbrain, pons, and medulla in the caudal fossa (below the tentorium cerebelli or infratentorial) and diencephalon in the more rostral middle fossa (above the tentorium cerebelli or supratentorial). Signs associated with lesions in the infratentorial brain stem are discussed below. Signs associated with the diencephalic (thalamic and hypothalamic) lesions are similar to those associated with cerebral lesions and so are discussed in the cerebral lesion section.

• Cranial nerve dysfunction is a common sign of brain stem disease. The brain stem contains cranial nerve 3 through cranial nerve 12 (CN3-CN12). Multiple or single cranial nerves may be involved in a disease process; signs are typically asymmetrical. CN5 through CN12 in the pons and medulla are more commonly affected than CN3 and CN4 in the midbrain.

M Key Point Central vestibular signs are usually present in diseases of the brain stem.

• Head tilt, circling, falling, disequilibrium, and nystagmus indicate damage to vestibular nuclei of CN8. Head tilts usually occur toward the side of the lesion. Paradoxical vestibular syndrome is characterized by a head tilt opposite the side of the lesion.

• Dysfunction of muscles of facial expression (CN7) and mastication (CN5) are common. Disorders of swallowing (CN9 and CN10), laryngeal function (CN9 and CN10), and tongue mobility (CN12) can occur but are less common.

• Oculomotor weakness, strabismus, and resting pupillary changes occur with CN3, CN4, and CN6 involvement.

• Injury to ascending white matter tracts in the brain stem results in ipsilateral conscious proprioceptive deficits and other abnormalities in postural reactions. Occasionally, ataxia, dysmetria, and exaggerated postural reactions may be seen.

• Injury to descending upper motor neuron (UMN) nuclei and their tracts in the brain stem causes tetraparesis or paralysis characterized by increased extensor muscle tone and exaggerated reflexes. The weakness or paresis is usually more severe in limbs on the same side as the lesion.

• Severe brain stem lesions can result in disruption of the ascending reticular activating system. Clinical signs of progressively decreasing levels of consciousness (depression, obtundation, stupor, coma) correlate with the severity of the injury.

• Severe brain stem lesions can also affect cardiovascular and respiratory regulation. Altered heart rate (bradycardia, supraventricular arrhythmias) and respiratory patterns (hyperventilation, ataxic respirations, apnea) are evident.

common. Hypermetria and limb circumduction can be seen. Strength and conscious proprioception (CP) are preserved. Postural reactions often are preserved but exaggerated.

• Truncal ataxia: Truncal swaying and a wide-based stance are typical of cerebellar disease. Affected patients may fall to one side. Dysmetric head bobbing with overshooting and undershooting occurs. Forward and backward movements of the trunk (titubation) may be seen.

• Intention tremor: A fine oscillating tremor of the head and sometimes the body is seen during highly controlled movements, such as eating or visually fixating on an object.

• Menace deficit: The menace response is lost ipsilateral to the cerebellar lesion. Vision and facial nerve function are intact.

• Anisocoria: Mild mydriasis may be seen ipsilateral to the cerebellar lesion.

• Vestibular signs: The cerebellum contains the flocculonodular lobe, which is considered part of the vestibular system. Lesions in this area of the cerebellum may produce pathologic (and often positional) nystagmus, head tilt, and circling. Occasionally, a pendular nystagmus (rhythmic but rapid horizontal oscillation of the eyes) is seen with cerebellar disease.

• Opisthotonus (extension of the head and neck) and thoracic limb extensor rigidity may be seen with severe cerebellar disease or with cerebellar herniation.

• Mental status is normal in patients with isolated cerebellar injury.

• Forebrain diseases can affect the cerebrum or diencephalon either bilaterally (diffusely) or unilaterally (focally). Both diffuse and focal forebrain disorders can cause the following: • Seizures (generalized or partial) • Behavior or personality change • Dullness, agitation, or otherwise inappropriate responses to environmental stimuli (abnormal mentation or "dementia") • Contralateral visual deficits (loss of menace) with intact pupillary light reflexes • Diffuse diseases of the cerebrum or diencephalon can also cause the following: • Generalized conscious proprioceptive deficits (all four limbs) • Stupor or coma with decreased to absent responses to painful stimuli • Generalized ataxia if an acute injury • Bilateral miosis with an intact pupillary light reflex • Focal diseases of the cerebrum or diencephalon can cause the following: • Circling toward the side of the lesion • Contralateral conscious proprioceptive deficits and slow postural reactions • Contralateral facial sensory deficits (especially nares sensation) • Contralateral mild facial weakness • Hemi-inattention to stimuli on the side of the body opposite the lesion • Focal diencephalic lesions may cause lethargy; inappetence; altered mentation and behavior; circling, listing, and/or head turn toward the side of the lesion; and hemi-inattention. These deficits may occur in the absence of proprioceptive, visual, or facial sensory and motor deficits.

• Structural intracranial lesions can produce referred head and neck pain.

M Key Point Cerebral and diencephalic diseases do not cause significant abnormalities of limb strength or weight bearing.

The above description of generalized and focal cerebral diseases applies to intracranial or structural disorders. Extracranial diseases (toxic, metabolic, and some nutritional disorders) may not produce actual structural lesions but may alter cerebral function enough to produce cerebral signs. Usually signs are diffuse in nature and mental status is altered. Seizures may be seen and may be either generalized or focal. Between seizures, lateralizing neurologic deficits are not found. Other body systems are often affected concurrently by systemic extracranial disorders.

• Space-occupying lesions in the forebrain and cerebellum may grow rapidly, may be accompanied by extensive edema, or may result in acute hemorrhage or infarction due to invasion of local blood vessels. Intracranial tissue and fluid compartments (parenchyma, blood, cerebrospinal fluid [CSF]) can compensate for space-occupying lesions up to a point. Beyond this critical threshold, brain shift or herniation occurs. Sudden changes in clinical signs not referable to the original neurolocalization suggest brain herniation and warrant emergency treatment.

• The two most common types of herniation are caudal transtentorial herniation due to an expanding forebrain mass and foramen magnum herniation due to an expanding cerebellar lesion.

• Clinical signs of transtentorial herniation include extensor rigidity in all four limbs and cervical musculature (decerebrate rigidity), pupillary constriction followed by dilatation or fixed, midrange pupils, loss of the vestibulo-ocular reflex (doll's eye reflex), and a stuporous or comatose state. • Clinical signs of foramen magnum herniation include opisthotonus (extended head and neck), thoracic limb rigidity (usually without rigidity of the pelvic limbs), pupillary changes (usually miosis), and either severely irregular respirations or apnea. • Appearance of these clinical signs indicates a severe brain injury and a need for immediate medical attention.

Primary and secondary brain tumors most commonly affect middle-aged and older dogs and cats and can be located anywhere in the brain. Direct mechanical compression and necrosis of surrounding brain parenchyma, peritumoral edema, and blood vessel invasion with hemorrhage may all contribute to signs of a spaceoccupying mass. Clinical signs reflect location of the tumor in a specific brain area. As discussed above, when brain compensatory mechanisms are exhausted, brain herniation occurs and rapid clinical deterioration ensues.

Brain tumors can be extra-axial, arising from more superficial areas of the brain and compressing or invading the underlying parenchyma, or intra-axial, arising deep within the brain parenchyma and invading neural tissue surrounding them. Extra-axial masses tend to have a gradual onset and slow progression of signs. Intra-axial tumors tend to have a more rapid onset and progression.

Primary tumors of the canine brain arise spontaneously and may grow slowly or rapidly.

M Key Point The two most common primary brain tumors in the dog are meningioma and glioma.

Etiologic factors are not well understood. The glioma group includes astrocytomas, glioblastomas, oligodendrogliomas, ependymomas, and choroid plexus papillomas or carcinomas. Meningiomas arise from arachnoid cells of the meninges, whereas gliomas arise from neuroectodermal supporting cells.

Meningiomas tend to occur in dolichocephalic breeds, whereas gliomas tend to occur in brachycephalic breeds. Any dog, however, may develop either tumor. Meningiomas in the dog are often located in the olfactory or frontal lobe or over the convexities of the cerebrum, but they can occur on the floor of the intracranial vault (rostral, middle, or caudal fossae). They often appear to be well-circumscribed masses but invade the underlying neural parenchyma. They may have a cystic component. Astrocytomas and oligodendrogliomas arise mostly from deep intra-axial locations in the brain (usually cerebrum or diencephalon). Ependymomas are relatively uncommon and arise from cells lining any of the ventricular compartments. The lateral ventricles of the cerebrum are the most common sites for ependymoma formation. Choroid plexus papillomas and carcinomas develop in areas of the brain where choroid plexus is present. The most common sites for a choroid plexus papilloma are the fourth ventricle-lateral aperture area and the third ventricle. Obstruction of the third ventricle by a choroid plexus papilloma results in secondary hydrocephalus and intracranial hypertension. Choroid plexus carcinomas, ependymomas, and, occasionally, oligodendrogliomas may metastasize to other central nervous system (CNS) areas using CSF pathways.

M Key Point The most common brain tumor of aged cats is the meningioma.

Most feline meningiomas are cerebrally located, extra-axial, and well encapsulated. They are frequently multiple and may occur anywhere along the falx, along the tentorium cerebelli, and in the tela choroidea of the third ventricle. Gliomas in the cat are uncommon but do occur. Primary CNS lymphoma may arise from brain structures, but it most commonly arises in thoracolumbar spinal cord locations.

Secondary tumors are either solitary or multiple. The two most common mechanisms of brain invasion are by hematogenous routes and by extension from surrounding tissues. Hemangiosarcoma, malignant melanoma, mammary adenocarcinoma, and pulmonary adenocarcinoma use the hematogenous route to metastasize to the brain. The most frequent metastatic location is the cerebrum. Secondary CNS lymphoma in dogs is usually associated with the multicentric form of lymphoma. Brain, cranial nerve, and spinal cord lesions can occur with concurrent leptomeningeal involvement. Multicentric malignant histiocytosis can secondarily invade the CNS in dogs (especially Bernese mountain dogs, rottweilers, golden retrievers). Forebrain, brain stem, spinal cord, and vertebral body invasion has been reported. Tumors that invade the brain by local extension include nasal adenocarcinoma, pituitary macroadenoma and carcinoma, and bony tumors of the skull including multilobular osteochondroma, osteosarcoma, and chondrosarcoma. Peripheral nerve sheath tumors of CN3 and CN5 also tend to grow up their respective nerve trunks and invade the brain stem. Ganglioneuromas in young dogs behave similarly.

Many of the same tumors that secondarily invade the canine brain also occur in the feline. These include metastatic carcinomas, nasal carcinomas, and pituitary carcinomas. Squamous cell carcinomas can extend into the brain from middle ear locations.

• The onset and progression of clinical signs depend on the type of tumor and its location. Extra-axial meningiomas grow slowly and clinical signs are gradual in onset and progression. Intra-axial gliomas grow rapidly and cause a more rapid clinical deterioration. Secondary tumors also tend to progress rapidly. An exception to this is the trigeminal neurofibroma, which exhibits very slow growth (months to years).

• Early clinical signs of forebrain tumors may be vague and include increased irritability, behavior change, pacing, head and neck pain, and increased lethargy. Head pain or headache in dogs can be recognized by gently applying bilateral pressure across the temporal aspects of the head and skull.

• Some forebrain tumors may be clinically "silent" or may only cause seizures. These tumors can be located in the olfactory, temporal, or occipital cerebral lobes.

M Key Point Signs of asymmetrical cerebral involvement include circling and contralateral conscious proprioceptive, visual field, and facial sensorimotor deficits.

• Diffuse cerebral signs may occur secondary to a tumor obstructing CSF flow. This results in fluid accumulation in the lateral ventricles of the cerebrum and secondary hydrocephalus.

• Herniation syndromes may occur with tumors of the forebrain or cerebellum (see under "Herniation from Space-Occupying Brain Lesions").

• Brain stem tumors usually occur in the pontomedullary area and typically cause central vestibular and other cranial nerve and long tract (e.g., limb proprioception and paresis) deficits.

• Cerebellopontomedullary angle tumors (choroid plexus papillomas, ependymomas, neurofibromas, meningiomas, and other tumor types) may invade the flocculonodular lobe of the cerebellum or the cerebellar peduncles. If this occurs, a "paradoxical vestibular syndrome" is seen. Signs are head tilt with possible circling and ataxia (rolling, falling, stumbling) away from the side of the lesion. The fast phase of nystagmus is often toward the side of the lesion. Long tract signs (e.g., limb proprioception and paresis), however, are ipsilateral to the lesion. If other cranial nerves are involved (e.g., CN5 and CN7), those deficits will be on the same side as the lesion.

• Cavernous sinus syndrome is a sporadic syndrome due to a lesion in the cavernous sinus along the floor of the rostral fossa (beneath the forebrain and just caudal to the orbital fissure). Neoplastic masses occupying this area will compress CN3, CN4, CN6, the ophthalmic branch of CN5, and the sympathetic nerve going to the eye. The result is an ipsilateral fixed pupil, absent corneal and eyelid sensation, and ocular immobility.

• Perform a complete blood count (CBC), chemistry profile, and urinalysis to rule out extracranial causes of brain dysfunction prior to pursuing tests for intracranial disease.

• Because most patients with brain tumors are older, run a geriatric screen of liver and kidney function.

• Perform an adrenocorticotropic hormone (ACTH) stimulation test and a low-dose dexamethasone suppression test if a pituitary mass is suspected.

Perform a complete ophthalmologic examination to check for papilledema (a sign of increased intracranial pressure [ICP]), uveitis, retinal hemorrhage, and other abnormalities.

• An electroencephalogram (EEG) may detect asymmetries in brain activity or actual epileptiform complexes if a seizure focus is present. See Chapter 125 for a more thorough description of the EEG and its uses.

• A brain stem auditory evoked response (BAER) may aid in localizing a brain stem lesion. See Chapter 125 for additional information.

• Perform thoracic radiographs to screen for metastatic disease.

• Skull radiographs are usually not helpful in the diagnosis of a brain tumor.

• Skull radiographs may reveal a nasal or bony tumor with secondary brain invasion.

• An area of bone sclerosis or lysis may be visible in the skull immediately adjacent to a feline meningioma.

• Some feline meningiomas may have an area of dystrophic mineralization that is visible on skull radiographs.

• Tumor margins and neuroanatomic location can be more precisely defined with computed tomography (CT) or magnetic resonance imaging (MRI). Peritumoral edema is also visible. Parenchyma definition, especially in brain stem areas, is best identified with MRI.

• Intravenous contrast agents (meglumine iothalamate for CT and gadolinium diethylenetriamine pentaacetic acid for MRI) highlight areas of blood-brain barrier disruption. Patterns of enhancement are not pathognomonic for tumor type but aid in making a tentative diagnosis.

• Inflammatory or other non-neoplastic lesions may mimic a neoplastic lesion on both CT and MRI. A CSF tap and biopsy of the mass are sometimes needed to confirm the underlying process.

M Key Point CT and MRI provide the precise neuroanatomic information needed for accurate biopsy, surgical, and/or radiation procedures. (See Chapter 4 for more information on these imaging modalities.)

For CSF tap technique and normal values, see Chapter 125.

• CSF analysis may be useful in distinguishing inflammatory from neoplastic processes (see also "Inflammatory Brain Diseases").

• The majority of brain tumors are characterized by no cytologic abnormalities (normal cell count and differential) on CSF analysis. CSF pleocytosis may be seen if the tumor is necrotic and has a secondary inflammatory component. Neoplastic lymphocytes in CSF are typically seen in dogs with CNS lymphoma.

• Protein levels are usually elevated for all tumor types.

Elevated protein with a normal cell count is called albuminocytologic dissociation.

M Key Point The CSF tap procedure is contraindicated in patients with elevated ICP.

• If clinical signs and/or CT or MRI suggest elevated ICP, the use of mannitol, furosemide, and hyperventilation may lessen the risks of brain herniation.

Brain biopsy can be performed either by open craniotomy or by using stereotactic CT guidance. Cytologic preparations of the biopsy can be examined intraoperatively and may be diagnostic.

• Corticosteroids primarily help in resolving vasogenic edema and often benefit patients with peritumoral edema. Administer prednisone at a dosage of 0.25 to 0.5 mg/kg every 12 hours as maintenance therapy for peritumoral edema.

• Meningiomas in cats may show a partial clinical response to corticosteroids in the short term (several weeks or months).

• If there is a rapid progression of signs due to a significant edema component, administer methylprednisolone sodium succinate (Solu-Medrol) at 30 mg/kg IV once followed by 15 mg/kg IV every 6 hours for 24 to 48 hours or dexamethasone at 1 mg/kg IV every 12 hours for 24 hours.

• Mannitol therapy is reserved for those patients with signs of increased ICP and/or herniation.

• In the euvolemic patient, mannitol at 1 g/kg IV over 20 minutes will draw fluid out of more normal areas of brain and temporarily lower ICP.

• Furosemide given 20 minutes after mannitol at a dose of 1 to 2 mg/kg IV will help prolong the effects of mannitol. Furosemide may also decrease CSF production.

Phenobarbital at a dosage of 2.2 to 2.5 mg/kg PO every 12 hours is indicated if seizures are part of the clinical picture (see Chapter 127). Potassium bromide is often required as an additional anticonvulsant if seizures are recurrent.

• Controlled clinical trials in dogs and cats have not been done to assess the true efficacy of different chemotherapeutic agents in the treatment of brain tumors.

• Nitrosoureas (lomustine, carmustine) appear to be beneficial in the treatment of some canine gliomas and meningiomas. Longer survival and even temporary tumor regression have been reported. Lomustine is also frequently effective against CNS lymphoma and malignant histiocytosis. Nitrosoureas are unique in that they cross the blood-brain barrier, the limiting factor for most chemotherapeutic agents. Give 50 to 80 mg/m 2 of body surface area every 4 to 6 weeks. For conversion of body weight to surface area (m 2 ), see Table 26 -4 in Chapter 26.

• Cytosine arabinoside reaches therapeutic CSF concentrations after large intravenous doses in normal dogs. Intrathecal and IV infusions of cytosine arabinoside have been used in dogs with CNS lymphoma. A dosage of 300 to 400 mg/m 2 of body surface area intravenously over 4 to 12 hours is recommended.

• Tumor cell heterogeneity with respect to relative phase in the cell cycle diminishes the likelihood of a uniform tumor response to chemotherapeutic agents.

• Craniotomy or craniectomy with tumor excision is a treatment option for extra-axial tumors involving the cerebrum or cerebellum. Refer the patient to a neurosurgical specialist.

M Key Point Survival rates are generally good to excellent when feline meningiomas over the cerebral convexities are removed surgically.

• It is usually years before clinically significant regrowth occurs after meningioma excision in cats. Survival periods of 6 months to 1 year are reported following meningioma excision in dogs. Postoperative radiation therapy extends the survival period in the canine (1-2 years).

• Tumors in more intra-axial and brain stem locations cannot be resected completely. Biopsy and radiation therapy (see below) can be performed.

M Key Point External beam megavoltage radiation therapy for brain tumors appears to prolong survival more consistently than other modes of therapy. A well-tolerated treatment protocol appears to be 45 to 48 Gy in 12 to 18 fractions over 3 to 4 weeks.

• Longest survival times for dogs with meningiomas are obtained when radiation therapy is combined with surgery.

• Canine pituitary tumors are radiation sensitive. Long remission times have been achieved.

• Brain metastases may respond to radiation therapy. • Clinical signs of neurologic dysfunction often improve rapidly (within 2-8 weeks) following radiation therapy. Tumor shrinkage is delayed (>4 months) and is not associated with early clinical improvement.

• Complications of radiation therapy include ocular (conjunctivitis, keratoconjunctivitis sicca, cataracts) and dermatologic (erythema, alopecia, otitis) changes. A potential late, delayed reaction may occur 9 to 24 months after radiation and is characterized by white matter necrosis.

• Stereotactic radiosurgery is the application of a single high dose of radiation delivered to a stereotactically defined target volume.

• The procedure utilizes multiple, non-coplanar beams originating from a radiation source that rotates in an arc around the patient's tumor. All beams are focused on the target in non-intersecting planes using a stereotactic image-based system.

• This radiation procedure reduces radiation exposure of normal brain tissue and so avoids adverse effects associated with conventional radiation therapy.

• Delivery of the entire radiation treatment as a single dose minimizes anesthetic events and reduces costly repeat visits associated with conventional radiation therapy.

Inflammation of brain parenchyma and its meninges (meningoencephalitis) occurs secondary to infectious or idiopathic insults.

M Key Point Idiopathic inflammatory conditions are more common than infectious conditions in dogs, but the reverse is true in cats.

Idiopathic disorders frequently have an immunemediated component. Most infectious agents reach the brain hematogenously. Local extension from extraneural sites, usually due to erosion through bone, is a mechanism used by some fungal and bacterial organisms. Other sources of infection include foreign body migration, previous trauma, and iatrogenic contamination during neurosurgery. An unusual but important mode of entry into CNS is that used by rabies and pseudorabies viruses and by Listeria bacteria. These agents are inoculated into a peripheral site, enter peripheral nerve axons, and then undergo retrograde axonal transport into the CNS.

The cascade of inflammatory changes that occurs after brain injury leads to a self-perpetuating process of brain tissue ischemia, necrosis, and edema. Inflammatory brain disorders are usually associated with multifocal clinical signs and lesions are often disseminated throughout the CNS. Clinical signs, however, may indicate a focal neurolocalization for the most prominent lesion. Some inflammatory disorders have a predilection for the cerebral cortex, whereas many others have a predilection for brain stem sites and frequently cause central vestibular signs. The onset and progression of clinical signs is usually rapid (days to weeks) but can be prolonged. Infectious diseases may be accompanied by systemic signs, but idiopathic brain conditions are usually characterized by signs referable to the CNS only. As in the case of neoplastic conditions, inflammatory diseases can lead to the formation of large, spaceoccupying lesions, increased ICP, and herniation of brain structures.

• Infectious diseases are a common cause of acute to subacute, rapidly progressive neurologic dysfunction in dogs and cats and tend to occur in young adults.

• Major etiologic categories include viral, fungal, rickettsial, and protozoal agents. Bacterial diseases of the CNS can also occur but are less common. Klebsiella, Escherichia coli, Streptococcus, Enterococcus, Staphylococcus, Pasteurella, Actinomyces, Nocardia, and various anaerobic species are the most common bacterial isolates. Some of the more important causes of infectious meningoencephalitis and their clinical and clinicopathologic features in the dog and cat are listed in Tables 126-1 and 126-2.

• Due to frequent multisystemic involvement seen with many infectious brain disorders, diagnostic testing should include ophthalmic exam, CBC, chemistry profile, urinalysis, thoracic radiographs, and sometimes abdominal ultrasound or echocardiography, and ophthalmologic examination. Both anterior uveitis and chorioretinitis are common with toxoplasmosis, rickettsial, and feline infectious peritonitis (FIP) infections. Chorioretinitis and optic neuritis may also be observed with cryptococcal and distemper infections.

• Cytologic evaluation of skin lesions, nasal exudates, liver and splenic aspirates, lymph node and bone marrow aspirates, joint fluid, and CSF can some-times identify the offending pathogen. Histopathologic evaluation of skin and muscle biopsies may also be useful to diagnose fungal and protozoal infections.

• CSF analysis in CNS infectious diseases frequently reveals a moderate to severe pleocytosis and elevated protein. Bacterial meningoencephalitis typically produces a neutrophilic pleocytosis with or without toxic changes in the neutrophils. Intracellular organisms are rarely observed. Blood, urine, and CSF cultures are indicated when bacterial infections are suspected even though CSF cultures are usually falsely negative. CSF characteristics of other CNS infections are described in Tables 126-1 and 126-2.

• CSF titers are preferred for diagnosis of distemper, cryptococcosis, and toxoplasmosis. An immunoglobulin G (IgG) ratio or intrathecal antibody coefficient for canine distemper virus (CDV) and toxoplasmosis can be determined using CSF and serum samples from affected animals. These methods correct for possible blood-CSF barrier breakdown by comparing CSF-to-serum ratios of pathogen-specific antibodies against ratios of vaccine-associated (usually adenovirus or calicivirus) antibodies. Non-paired serum titers for toxoplasmosis are unreliable in the dog and cat due to persistence of high antibody titers long after exposure. The antibody coefficient calculation may also be useful to diagnose CNS FIP, although false-negative cases of CNS FIP have been reported. Cryptococcal antigen-specific titers can be run on serum, but CSF titers provide a more definitive diagnosis of CNS involvement. Cryptococcal antibody titers may be falsely negative due to an inadequate humoral immunologic response to the encapsulated organism. Serum titers are useful for diagnosis of neosporosis and rickettsial diseases. Neospora caninum serum antibody titers are usually very high (>1:800) in infected dogs and do not crossreact with toxoplasmosis titers. Dogs exposed to the organism but without clinical signs of infection may also have high titers.

• MRI features of CNS infectious diseases include patchy edema and focal to multifocal contrastenhancing lesions of the parenchyma. Some fungal and protozoal granulomas and bacterial abscesses can ring enhance. Edema can be severe with bacterial encephalitis. Meningeal enhancement is common, especially with bacterial meningoencephalitis. FIP is spinal cord and mild protein brain stem signs (often multifocal) *Preferred treatment(s) are listed first; other available drugs are listed in parentheses. AEDs, antiepileptic drugs; CDV, canine distemper virus; CF, complement fixation antibody; CSF, cerebrospinal fluid; IFA, immunofluorescent antibody; NA; not available; PCR, polymerase chain reaction; RMSF, Rocky Mountain spotted fever; RT-PCR, reverse transcriptase polymerase chain reaction. often characterized by periventricular and meningeal contrast enhancement and ventricular dilatation due to secondary hydrocephalus. Fungal granulomas and bacterial abscesses may resemble intracranial tumors due to their patterns of enhancement and perilesional edema.

• Occasionally, a brain biopsy may be needed to make a definitive diagnosis.

• Medical therapy for infectious brain diseases is presented in Table 126 -3. Protozoal and fungal infections frequently require prolonged therapy. The recommended treatment duration for CNS cryptococcal and coccidioidal infections with fluconazole is 9 to 12 months. In dogs, treatment of cryptococcal infections is stopped after two consecutive negative titers are obtained at least 4 weeks apart. Relapses are common if fluconazole therapy is stopped too early.

• Initial treatment of bacterial meningoencephalitis is most effective if parenteral antibiotics are administered. Parenteral (usually intravenous) administration allows rapid therapeutic CNS and CSF drug concentrations to be achieved. Penicillin or ampicillin in combination with third-generation cephalosporins have a broad antimicrobial spectrum and are bactericidal (see Table 126 -3). Many third-generation cephalosporins also cross the blood-CSF and bloodbrain barrier in both the presence and the absence of inflammation. Concurrent low-dose dexamethasone therapy (0.15 mg/kg IV every 6-8 hours for 4 days) has been shown to be beneficial in human bacterial meningoencephalitis. After 3 to 5 days of parenteral therapy, inflammation resolves and the barrier to the entry of many antibiotics is restored. Extended therapy is then instituted with broad-spectrum oral antibiotics that penetrate non-inflamed meninges. These drugs include trimethoprim-sulfonamide, chloramphenicol, florfenicol, and fluoroquinolones. Metronidazole is often added if an anaerobic component to the infection is suspected.

M Key Point Treatment failures usually relate either to delays in antibiotic administration or to selection of antibiotics with an inadequate spectrum, poor CNS penetrating abilities, or lack of bactericidal properties.

Also refer to "Infectious Causes of Vasculitis" later in this chapter. Additional information can be found in the following chapters: 

Granulomatous meningoencephalomyelitis (GME) is an idiopathic, immune-mediated condition in dogs characterized by pronounced inflammatory changes in the CNS. These changes tend to predominate in white matter areas of the brain and spinal cord. Perivascular accumulations of lymphocytes, plasma cells, and histiocytic-like cells are the hallmark of GME. Some perivascular cell aggregates may coalesce to form a space-occupying mass in the brain. GME should be distinguished from neoplastic reticulosis and from B cell lymphoma in which homogeneous populations of neoplastic cells predominate. Whether inflammatory cells in GME eventually undergo neoplastic transformation to these cancerous phenotypes is still unknown. At present, the mixed granulomatous cell response is believed to represent a chronic immune response to a suspected but unconfirmed antigen.

Three forms of GME have been described. The disseminated form is characterized pathologically by multifocal perivascular cuffs throughout the brain and spinal cord and clinically by multifocal neurologic signs. The focal form is characterized by a focal neurolocalization due to the presence of a granulomatous mass in the brain stem, the cerebrum, or more rarely, the spinal cord. The focal form, however, is probably a variant of the disseminated form since histologic lesions can usually be identified postmortem all throughout the neuraxis. A rare optic form with dense optic nerve infiltration by inflammatory cells is also recognized.

• GME is primarily a disease of toy and small breeds between 1 and 8 years of age. Large-breed dogs may occasionally be affected (e.g., Airedale terriers).

• Onset and progression of clinical signs may be more rapid (several days) in the disseminated form compared with the focal form (1-3 weeks).

• Initially, mild fever, lethargy, and intermittent anorexia may be the only clinical signs seen.

M Key Point Neurologic signs of GME often indicate a focal brain stem or cerebral lesion.

• Central vestibular signs are common and may be paradoxical (see "Neoplasia"). Long tract signs (proprioceptive deficits and paresis) and other cranial nerve deficits (CN5 and CN7) may be present.

• Neck pain is often present and indicates meningeal involvement.

• Focal or multifocal areas of intramedullary spinal cord inflammation (myelitis) may cause tetraparesis or caudal paresis.

• The optic form is characterized by a sudden onset of bilateral or unilateral blindness.

• A marked mononuclear pleocytosis consisting of lymphocytes, plasma cells, monocytes, macrophages, and multinucleated giant cells is usually evident on CSF analysis. Neutrophils may be present. Rarely, CSF cytology is normal. Protein is usually elevated.

• CSF titers, cultures, and virus isolation studies are negative for any infectious etiology.

• CT or MRI may reveal focal or multifocal contrastenhancing lesions (homogeneous or heterogeneous) with edema in white matter adjacent to the lesions.

• GME is a diagnosis of exclusion. A predominant mononuclear CSF pleocytosis and negative tests for infectious agents (rickettsial, fungal, bacterial, protozoal, viral) suggest a diagnosis of GME. If the CSF is normal and a focal lesion is present, a brain biopsy is necessary to rule out neoplasia.

• Prednisone at 2 mg/kg every 12 hours for 2 weeks, then 1 mg/kg every 12 hours for 1 to 2 months fol-lowed by a gradual taper over several months, will usually result in temporary remission of clinical signs in the focal form. The disseminated form has a less favorable response to therapy. The optic form, if treated in the early stages, can result in recovery of vision.

• Other therapies for GME include lomustine, azathioprine, cytosine arabinoside, procarbazine, cyclophosphamide, and cyclosporine. I prefer lomustine as maintenance therapy. The dosage is 60 mg/m 2 of body surface area every 4 to 6 weeks for 12 to 24 months. Lomustine therapy can be initiated early in the course of corticosteroid therapy.

• Radiation therapy for the focal form of GME may be of benefit as adjunctive therapy.

Relapses are common and may occur weeks to months (up to 48 months) following onset of therapy. Upon relapse, patients are often refractory to a second course of chemotherapy.

Necrotizing encephalitis is a brain disease of toy breeds (pugs, Maltese terriers, and Yorkshire terriers). The acute disease bears many similarities to GME and may have an immune-mediated component. Lymphocytes and histiocytes form large perivascular cuffs in cerebrum. Neuronal necrosis and malacia in both gray and white matter are more severe in necrotizing encephalitis than in GME. Multifocal, necrotic, cavitating lesions are commonly observed in the chronic stages. A familial predisposition is probable, but this disorder is considered idiopathic.

• Age of onset of clinical signs is 9 months to 5 years of age.

• Seizures, dementia, blindness, neck pain, and ataxia are seen in the acute form. Over 1 to 2 weeks, signs may or may not progress to coma and/or status epilepticus.

• In the chronic form, partial or generalized seizures are initially seen but the interictal neurologic examination is normal. Other forebrain signs and progressive seizure activity develop over the subsequent 4 to 12 months.

• Brain stem and cerebellar signs are also reported.

• A diagnosis of necrotizing encephalitis is supported by clinical signs and a CSF mononuclear pleocytosis. Small lymphocytes predominate in the majority of affected dogs. More pronounced pleocytosis is seen in the acute form or in the early stages of the chronic form. Protein levels are increased.

• MRI in the acute form shows asymmetrical cerebral edema that affects white and gray matter. Patchy or scant contrast enhancement may be seen acutely. In chronic cases, MRI changes include asymmetrical cortical cavitation, ventriculomegaly, and atrophy. Cavitated, cystic lesions are frequently periventricular. Chronic lesions fail to contrast enhance. Concurrent thalamic, midbrain, and cervical lesions have also been identified in selected cases.

• The primary differential diagnoses are GME, infectious disease, and neoplasia. An additional differential diagnosis for the chronic form is cerebrovascular disease.

Use immunosuppressive therapy as for GME and anticonvulsant therapy.

The prognosis is guarded to poor.

An acute onset of tremor in toy-to small-breed dogs with white coat color (Maltese terrier, West Highland white terrier, poodle, Bichon frisé, Samoyed) is recognized. Other breeds with other coat colors (beagle, miniature schnauzer, spitz, Yorkshire terrier, etc.) can also be affected. This syndrome was originally described by some authors as a "non-suppurative encephalitis" or "cerebellitis" due to the occasional finding of a nonsuppurative meningoencephalitis involving the cerebellum and other brain areas. A demyelinating disorder, a neurotransmitter defect, and various other mechanisms have been hypothesized but not proven.

• Young adult dogs (less than 6 years of age) are affected.

• The onset is acute to peracute. • Clinical signs are a severe coarse head and body tremor that worsens with stress, exercise, or handling. At rest or during sleep, the tremor diminishes. Continuous shaking makes ambulation difficult, but strength and motor abilities are preserved. The excessive muscle activity may cause hyperthermia.

• Disconjugate, jerky eye movements may be seen (opsoclonus).

• Dogs are alert and responsive and rarely have other neurologic deficits.

• Differential diagnoses include neurotoxin exposure ("moldy cheese" toxicity, metronidazole toxicity), other inflammatory CNS diseases, and generalized seizures. Generalized tremors in the absence of other signs of neurologic or systemic illness suggest a diagnosis of shaker syndrome.

• CSF may be normal or a mild lymphocytic pleocytosis may be seen.

• Cool the patient if hyperthermic. • Diazepam, 0.5 to 1.0 mg/kg PO every 8 hours, will help alleviate signs in the short term.

• Prednisone, 1 mg/kg every 12 hours for 4 weeks followed by a gradual taper over the next 8 weeks, appears to be the most effective treatment. Some dogs may recover without therapy.

• The prognosis is good for recovery. Relapses may occur.

Etiology Vascular encephalopathies can affect the forebrain, cerebellum, or brain stem of dogs and cats. Affected animals are usually older. Signs are peracute and rarely progressive. Focal ischemia or infarction ("stroke") usually occurs due to thrombosis of a brain blood vessel secondary to hypercoagulable states, hyperviscosity syndromes, atherosclerosis, vasospasm (from hypertension), local vasculitis, tumor emboli, or tumor invasion of regional blood vessels. A primary cause may not be found in many cases. Spontaneous hemorrhage in the CNS can occur due to thrombocytopenia, coagulopathies, vasculitis (immune-mediated or infectious), neoplastic invasion of blood vessels (especially from hemangiosarcomas), traumatic or ischemic damage to vessels, or arteriovenous malformations or aneurysms. Traumatic injuries to the brain and its vessels are discussed under "Brain Trauma." Other common causes of vascular disease in small animals are discussed in subsequent sections.

• Common zones of ischemia in the dog and cat include those brain areas supplied by the middle cerebral artery (forebrain) and rostral cerebellar artery (cerebellum).

• Signs of focal ischemia are almost always asymmetrical and reflect the areas of the CNS involved. Signs of unilateral forebrain disease (seizures, circling, dementia, aggression, contralateral blindness, and CP deficits) and signs of cerebellovestibular disease (ataxia, head tilt, nystagmus, hypermetria, torticollis) may be seen. Some dogs with cerebellar infarcts may show paradoxical vestibular signs.

• Hypercoagulable states can occur due to renal disease with protein-losing nephropathy, Cushing's disease, and septicemia. A CBC, chemistry profile, urinalysis, urine protein-to-creatinine ratio, ACTH stimulation test, thoracic radiographs, and abdominal ultrasound are necessary to rule out these disorders.

• Atherosclerosis can occur due to hypothyroidism and is also recognized in miniature schnauzers with hyperlipoproteinemia. A thyroid panel, fasting triglycerides, and a lipid/cholesterol panel are recommended.

• Hypertension in dogs and cats may be associated with hypothyroidism, hyperthyroidism, Cushing's disease, diabetes mellitus, renal insufficiency, hepatic insufficiency, pheochromocytoma, and phenylpropanolamine administration. Idiopathic or essential hypertension is also being recognized with greater regularity. Serial blood pressure monitoring, retinal examination, and appropriate testing to rule out the above disorders are warranted if hypertension is present (see Chapter 153).

• Hyperviscosity syndromes can occur secondary to gammopathies, polycythemia vera, and hyperfibrinogenemia. Protein electrophoresis and coagulation profiles may be indicated.

• MRI is very important in determining the extent of the ischemia or hemorrhage and potential local concurrent conditions (tumor, inflammation, arteriovenous malformation) that could have produced it. Pure areas of ischemia are primarily hypointense on T1-weighted images and hyperintense on T2weighted and fluid-attenuated inversion recovery images. Secondary edema, especially during reperfusion, can cause a transient mass effect with signs of acute brain swelling, but this is not common and usually no mass effect is evident. Contrast enhancement is minimal to absent in most cases, although a peripheral rim enhancement of the lesion can be seen starting 1 week after onset. Chronically, large areas of infarction "collapse" due to atrophy and loss of parenchymal volume. A paradoxical "mass effect" could be incorrectly diagnosed due to a contralateral shift of the brain midline and ventricles toward the side of the infarction.

• CSF analysis can be normal or show a mild increase in cells and protein. If acute, cells may be predominantly neutrophils.

• Treatment for brain ischemia depends on the severity of the event and the correction of an existing underlying cause.

• Severe infarction can cause secondary brain edema that could require mannitol therapy (0.5-1.0 g/kg IV over 20 minutes). Careful but adequate fluid therapy to maintain a euvolemic state is essential.

• Anticonvulsants may be necessary if seizures occur.

Anticonvulsant drugs that have fewer sedative properties (felbamate, zonisamide, gabapentin, levetiracetam) will permit better assessment of neurologic recovery.

• Hypertension can usually safely be treated with angiotensin-converting enzyme inhibitors (enalapril) or vasodilators (amlodipine, prazosin). Heparin, warfarin, and aspirin are used routinely in humans after a stroke if atherosclerosis is suspected. Treatment of any predisposing causes of vascular disease is essential.

M Key Point Vascular encephalopathies can cause severe signs initially, but many of the signs improve steadily with time (over 2-3 months) and generally have a good prognosis.

This is an idiopathic syndrome of young to middle-aged cats characterized by a peracute onset of unilateral cerebral infarction due to vasospasm of the middle cerebral artery. The pathogenesis of this disease is not well understood. It is usually not associated with thromboembolic disease secondary to feline hypertrophic cardiomyopathy or any other etiology. An association between aberrant Cuterebra species migration in brain and possible middle cerebral artery vasospasm has been suggested because of the occasional finding of this parasite in the cranial vault. There is a higher incidence of this syndrome in late summer.

• Affected cats often exhibit peracute signs of unilateral cerebral dysfunction. Altered mentation, behavior change, circling, visual field deficits, contralateral postural deficits, seizures, or a combination of these signs may be observed.

• Seizures may be the only clinical sign observed. • Signs may worsen slightly over 24 to 48 hours but then stabilize.

• If the injury is not fatal, signs may steadily improve over days to months.

• Seizures and altered personality may be long-term sequelae.

• Rule out other causes of unilateral cerebral dysfunction and peracute vascular disease (cardiomyopathyassociated thromboemboli, hypertension, hypercoagulable states, infectious vasculitis, neoplasia, trauma).

• CSF analysis may reveal a pleocytosis and elevated protein due to inflammatory changes induced by necrotic tissue.

• MRI in acute stages demonstrates cerebral edema, usually without significant mass effect. Chronically, asymmetrical atrophy of cortical regions supplied by the middle cerebral artery will be seen.

• The peracute onset of signs in an otherwise healthy cat aids in making a tentative diagnosis.

• There is no specific treatment. 

The prognosis for survival is fair to good. The prognosis for complete recovery is guarded.

Etiology A necrotizing vasculitis of young adult beagles, Bernese mountain dogs, and German shorthaired pointers is frequently associated with neurologic signs. This is an idiopathic condition, but a genetic predisposition is suspected. The typical lesion is a fibrinoid necrosis and thrombosis of small-and medium-sized meningeal vessels with subsequent meningeal fibrosis. A marked inflammatory component to the lesion suggests an immune-mediated basis for the disease. Meningeal artery damage may lead to hemorrhage or to thrombosis or infarction of adjacent neural parenchyma.

• Age of onset is 3 to 18 months of age. • Signs of meningitis (neck pain and stiffness, stiff, stilted gait, fever) are common. "Painful" episodes may wax and wane. Clinical signs of meningitis are very similar to sterile suppurative meningitis of young, large-breed dogs.

• Secondary parenchymal involvement may result in conscious proprioceptive deficits and paresis. Rarely, cranial deficits occur.

• Blindness and seizures are seen secondary to an associated encephalitis in Bernese mountain dogs.

• Beagles may have neutrophilic polyarthritis and coronary arteritis associated with the neurologic disease.

• CSF analysis is characterized by a marked neutrophilic pleocytosis and elevated protein levels. No infectious agents can be isolated, and titers for infectious causes of meningitis (rickettsial, viral, bacterial, fungal, protozoal) are negative.

• GME can be ruled out based on the CSF findings. • Intervertebral disc disease is ruled out by the demonstration of no compressive lesions on cervical myelography.

• Antinuclear antibody titers are negative, and there is no evidence of neoplasia or a drug reaction.

• Immunosuppressive dosages of corticosteroids (2 mg/kg PO every 12 hours for 2 weeks with a very slow taper over 3-6 months) often result in a clinical response.

• Occasionally patients are nonresponsive and may require other immunosuppressive agents.

The prognosis is fair to guarded. Some patients do not respond to therapy. Relapses can occur.

Many of the infectious causes of vasculitis have previously been discussed in "Inflammatory Brain Diseases" (see Tables 126-1 and 126-2). Various fungal, protozoal, and viral agents may create secondary blood vessel inflammation with edema, hemorrhage, or infarction. Rickettsial disorders may produce an immune-mediated vasculitis and direct damage to endothelial cells due to intracellular replication. Bacterial vasculitis occurs most commonly as a sequela to sepsis. Bacterial toxins and inflammatory mediators released by neutrophils increase vascular permeability and cause edema and hemorrhage. Septic thromboemboli lead to multiple areas of infarction.

• Diffuse or multifocal vasogenic edema can result in brain swelling and diffuse cerebral signs of dullness, dementia, head pressing, and pacing. Signs of brain herniation may be evident.

• Head and neck pain are common due to accompanying meningitis.

• Multifocal cranial nerve deficits and long tract signs reflect multifocal involvement of the brain stem and spinal cord. Rickettsial diseases are often associated with central vestibular signs.

• Focal or generalized motor seizures and other focal cerebral signs may be seen.

• Systemic signs of fever, lymphadenopathy, polyarthritis, uveitis, and peripheral edema are sometimes present.

• CSF characteristics will depend on the inciting cause (see "Inflammatory Brain Diseases" and Tables 126-1 and 126-2). The degree of pleocytosis is often determined by the degree of meningitis. Bacterial vasculitis is characterized by normal or neutrophilic pleocytosis and high protein levels.

• Xanthochromia, free blood, and erythrophagocytosis by neutrophils or macrophages are typical CSF findings in patients with previous hemorrhage.

• Gram stains and other special stains may demonstrate organisms.

• Appropriate CSF titers and cultures will often reveal the underlying pathogen.

• A CBC, a chemistry profile, and other blood tests will frequently uncover abnormalities in other organ systems.

• Treatment is directed at the underlying etiologic agent.

• See "Inflammatory Brain Diseases" and Table 126-3 for properties of specific antimicrobial agents.

The prognosis will vary depending on the underlying pathogen, its sensitivity to chemotherapies, and the state of disease progression. Aggressive medical therapy is necessary to prevent irreversible brain injury.

Severe head trauma can result in acute brain injury. Primary mechanical injury to cell membranes and fiber tracts results in irreversible necrosis. This can take the form of a blunt contusion or a laceration. Secondary events are due to biochemical changes at the cellular level and increased ICP. Excitotoxins, free radicals, prostaglandins, and inflammatory cytokines fuel a selfperpetuating cycle of ischemia and necrosis in the traumatized brain. Intracranial edema and hemorrhage combine to raise ICP, exhaust compensatory mechanisms, and create conditions favorable for brain herniation. Elevated ICP may also lead to bradycardia, systemic hypertension, and neurogenic pulmonary edema. A final immediate or delayed consequence of brain trauma is epilepsy. Seizures can be seen months following head trauma.

• The signs of brain trauma will depend upon whether the lesion remains localized or progresses to involve other brain structures. If progression occurs, it will occur within the first 24 to 48 hours after an injury. For this reason, it is critical to perform serial neurologic examinations every few hours in traumatized patients.

• Focal signs may originate from injury to the cerebrum, cerebellum, or brain stem and will reflect dysfunction of the region involved.

• Signs of increased ICP, transtentorial herniation, and foramen magnum herniation are discussed in the first section of this chapter, under "Herniation from Space-Occupying Brain Lesions." An orderly progression of signs due to increased ICP can be graded from mild to severe. • Motor activity tends to progress from normal ambulatory status to recumbency with progressive extensor rigidity. • Pupils initially appear miotic but soon become mydriatic or midrange and nonresponsive to light. • The oculovestibular reflex (doll's eye) is lost in the late stages of transtentorial herniation and is a poor prognostic sign. • Level of consciousness deteriorates from the alert state to depression, stupor, and coma. These states are defined by the patient's responsiveness to stimuli, including deep pain. • Hyperventilation may be seen with midbrain compression, whereas either an ataxic (irregular) respiratory pattern or apnea may be seen with medullary compression.

• Clinical signs usually reflect the severity of the injury. • Use an EEG and BAER can be used to localize areas of brain damage (see Chapter 125). The EEG can also be used to detect seizure foci.

• Consider CT and MRI in those patients with progressive neurologic dysfunction despite medical therapy or if unstable skull fractures are present. Progression of clinical signs may occur secondary to a space-occupying epidural or subdural hematoma or secondary to compression and/or laceration of brain parenchyma by a depressed or displaced skull fracture. CT is often preferred over MRI due to its sensitivity to bony changes and intracranial hemorrhage and also the shorter examination time required compared with MRI.

• A CSF tap is rarely necessary. It is contraindicated in the patient with increased ICP.

• Correct hypovolemic shock, pneumothorax, cardiac arrhythmias, and other life-threatening non-neural injuries. When correcting for shock, do not overhydrate the patient.

• Elevating the head will facilitate venous return to the heart, enhance CSF resorption, and help maintain cerebral blood flow. Avoid jugular vein compression when elevating the head.

• Hypercarbia will act to cause cerebral vasodilation and increased ICP. Intubation and hyperventilation will lower blood and brain carbon dioxide concentrations and stimulate vasoconstriction. Vasoconstriction of cerebral vessels will decrease intracranial blood volume, lower ICP, and raise cerebral perfusion pressure.

• Methylprednisolone sodium succinate (Solu-Medrol) may be of some benefit if administered at the time of or immediately following the trauma (within 1 to 2 hours). Administer methylprednisolone sodium succinate at 30 mg/kg as an intravenous bolus, then give repeat boluses of 15 mg/kg IV at 2 hours and then every 6 hours for 1 to 2 days. After this, discontinue the steroids.

• Mannitol and furosemide are administered if signs of impending herniation are present. Administer a single (1 g/kg) IV bolus of mannitol as a 20% solution at a rate of 2 ml/kg/min. Administer 0.7 mg/kg of furosemide IV 15 minutes after mannitol. Furosemide will prolong the effects of mannitol and decrease CSF production.

• Use hypertonic saline (7.5% as a 4 ml/kg IV bolus)

with hydroxyethyl starch (20 ml/kg IV) in a patient that presents with both hypovolemic shock and head trauma or cerebral edema. Hypertonic saline will lower ICP as long as there is no bleeding from a major vessel. Hydroxyethyl starch will prolong the effects of the hypertonic saline. Follow these boluses with lactated Ringer's solution at a dosage of 40 to 50 ml/kg/hour. If there is significant bleeding, administer whole blood or plasma at 25 ml/kg over 1 hour (do not use hypertonic saline or mannitol). Follow with lactated Ringer's solution at a dosage 40 to 50 ml/kg/hour. Fluid therapy is discussed in Chapter 5 and management of shock is described in Chapter 156.

• Administer intravenous diazepam to control seizures.

Intravenous phenobarbital and other anticonvulsants may be needed in some cases (see Chapter 127). Initiate oral anticonvulsant (phenobarbital) therapy and do not taper or discontinue treatment unless the patient remains seizure free for a minimum of 6 months.

• Monitor supportive fluid therapy to prevent overhydration or dehydration (see Chapter 5). Patients should be turned and kept on padded bedding. Intermittent bladder expressions or catheterizations may be necessary. Initiate parenteral or enteral nutritional support as needed (see Chapter 3).

The brain relies on the body's various homeostatic mechanisms to control extracellular osmolality, electrolyte concentrations, acid-base balance, oxygenation, and glucose levels. Potentially neurotoxic metabolites are continuously removed from the body by fully functional hepatic and renal systems. If homeostatic mechanisms are disrupted, normal brain function may be impacted and physical brain injury may occur. The cerebrum is often the major brain region affected by metabolic encephalopathies. Altered behavior, depressed mentation, and seizures are common manifestations of diffuse cerebral dysfunction. 

Thiamine is a water-soluble B vitamin that is an essential dietary nutrient. Depleted body stores of thiamine may be a result of deficient thiamine in the diet, a prolonged period of anorexia, or chronic ingestion of allfish diets containing thiaminase. Thiamine deficiency results in altered energy metabolism, decreased adenosine triphosphate (ATP) formation, and eventual cell death. Neurons in brain stem nuclei are most vulnera- 

• Signs may be intermittent initially but are rapidly progressive once present. Affected cats are often thin or on a poor diet.

• Head and neck ventroflexion and ataxia may progress to recumbency, extensor rigidity, opisthotonus, and coma.

• Ocular changes include mydriasis, sluggish to no pupillary light reflexes, blindness, and absence of the oculovestibular reflex.

• Positional vertical nystagmus is common. Seizures may be present.

• Sudden death can occur 24 to 48 hours after onset of signs.

• Rule out other causes of acute brain stem or central vestibular signs in the cat, including FIP, cryptococcosis, toxoplasmosis, and vascular disorders.

• CSF may show a slight pleocytosis and protein elevation and/or xanthochromia due to ongoing necrosis and hemorrhage.

• Erythrocyte transketolase activity may be decreased and blood pyruvate and lactate levels may be increased.

• Blood thiamine levels may be normal or decreased. • Response to therapy is the usual method of diagnosis.

• Give parenteral thiamine at a dosage of 25 to 50 mg per cat intramuscularly or subcutaneously every 12 hours until signs resolve.

• Institute a balanced diet and supplement with B vitamins for at least 2 weeks.

• A dramatic response to thiamine is usually seen in 24

to 48 hours.

The prognosis is good with prompt therapy. If pretreatment signs are severe, the response may be incomplete. The condition is fatal if no treatment is instituted.

A variety of toxins can affect the CNS in dogs and cats. Multisystemic signs may or may not be present. Any region of the neuraxis can be affected. Those neurotoxins that result in signs of brain dysfunction are discussed below. For most ingested toxins, general treatment guidelines include the following:

• Induction of vomiting with 2 ml/kg of 3% hydrogen peroxide (except in comatose or obtunded patients or in the case of petroleum distillate or alkali ingestion) if it has been less than 2 hours since ingestion.

• Gastric lavage under anesthesia if it has been less than 2 hours since ingestion. Use 5 to 10 ml/kg of water for each lavage and lavage several times. Leave activated charcoal in the stomach after the final lavage.

• Administration of activated charcoal 2 g/kg orally by stomach tube.

• Administration of a cathartic (usually magnesium sulfate) at the same time as or 30 minutes following activated charcoal administration.

• Colonic lavage and enemas (especially for heavy metals).

Lead poisoning is a sporadic problem caused by ingestion of lead-containing paint chips, plaster board and sheetrock, grease, crankcase oil, linoleum, battery parts, solder, putty and caulking material, roofing material, and occasionally lead-contaminated soil. Younger animals are more frequently affected than older animals due to chewing tendencies, increased gastrointestinal absorption, and increased blood-brain barrier permeability. Acute toxicity is generally seen, but chronic exposure to low levels of lead may lead to a cumulative toxicity. Within the CNS, lead causes endothelial cell damage, edema, hemorrhage, and cerebrocortical laminar necrosis.

• Acute systemic signs of vomiting, diarrhea, anorexia, and abdominal pain may be seen. A rare finding is megaesophagus.

• Neurologic signs include hysteria, behavior change, pica, vocalization, and blindness.

• Either generalized or focal motor seizures may be present. "Chewing gum" seizures and myoclonus may be observed.

• A blood lead level greater than 40 mg/dl is suggestive of lead poisoning. A level greater than 60 mg/dl is diagnostic for lead poisoning.

• Urinary lead levels will be elevated approximately 24 hours after the start of chelation therapy.

• Abdominal radiographs may reveal radiopaque material in the gastrointestinal tract.

• Nucleated red blood cells and basophilic stippling are often evident on stained blood smears.

• If lead is visible in the gastrointestinal tract, administer cathartics and enemas.

• Use any one of the following chelating drugs:

• Calcium disodium ethylenediaminetetraacetic acid at 25 mg/kg SC every 6 hours for 5 days. Prepare a 1% solution in 5% dextrose in water. Side effects are anorexia, diarrhea, and nephrotoxicity. • D-penicillamine at 110 mg/kg/day PO divided into three or four doses every 6 to 8 hours for 2 weeks. Gastrointestinal side effects are common. • 2,3-Dimercaptosuccinic acid at 10 mg/kg/day PO for 10 days. Side effects are rare.

• Administer anticonvulsants for seizures (diazepam, phenobarbital) (see Chapter 127).

• Treat suspected cerebral edema with mannitol and corticosteroids.

The prognosis is fair to good if neurologic debilitation is not severe. Residual neurologic deficits and seizures may be long-term sequelae.

Metaldehyde is a molluscide that can produce signs of neurotoxicity after oral ingestion. Metaldehyde produces a severe metabolic acidosis. Levels of the CNS neurotransmitters gamma-aminobutyric acid (GABA), norepinephrine, and serotonin are decreased in affected animals. The exact mechanism of neurotoxicity is unknown.

• Seizures, tremors, depression, salivation, tachycardia, hyperesthesia, hyperthermia, vomiting, and diarrhea are seen peracutely. Cats may also have nystagmus and ataxia. Respiratory failure may develop within 24 hours.

• If animals survive the initial toxic insult, hepatic failure occurs 3 to 4 days after ingestion.

• Compatible signs, acidosis, and a history of exposure are suggestive of metaldehyde intoxication.

• A definitive diagnosis can be made by chemical analysis of stomach contents, urine, or liver tissue.

• Perform gastric lavage and administer activated charcoal if it is within 2 hours of ingestion.

• Use sodium bicarbonate to treat the acidosis. • Anticonvulsants are indicated for seizure control (see Chapter 127).

The prognosis for recovery is poor.

Ingestion of stimulants containing caffeine, theophylline, aminophylline, or theobromine may produce signs of methylxanthine toxicosis. Chocolate contains both caffeine and theobromine. Ingestion of 1 ounce of baker's chocolate per kilogram of body weight can be lethal in the dog. Although it is known that methylxanthines inhibit phosphodiesterases, increase calcium influx into cells, and enhance catecholamine release, the mechanism of its neurotoxicity is unknown.

• Tachycardia, cardiac arrhythmias, vomiting, polyuria and polydipsia, hyperthermia, respiratory paralysis, and cyanosis.

• Acute signs occur within several hours of ingestion and include seizures, hyperactivity, muscle tremors, ataxia, and coma.

• Drug or chocolate exposure and clinical signs allow a tentative diagnosis of methylxanthine toxicosis.

• Serum, stomach contents, and urine can be analyzed for methylxanthine levels.

• Administer activated charcoal and promote diuresis with aggressive fluid therapy.

• Treat cardiac arrhythmias with antiarrhythmic agents (see Chapters 145 and 146).

• Use diazepam for muscle tremors and seizures.

The prognosis is fair to good if treatment is instituted early.

Both organophosphates and carbamates inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine at muscarinic and nicotinic sites of the autonomic and somatic nervous systems. Usually signs of parasympathetic stimulation predominate, but signs of somatic, sympathetic, and CNS overstimulation may also be present. Delayed organophosphate neurotoxicity can cause an irreversible central-peripheral axonal degeneration. Chlorpyrifos, dichlorvos, fenthion, carbaril, methonyl, aldicarb, and carbofuran are just a few of the insecticides that can be toxic after dermal application or following oral ingestion. Many of these insecticides are found in dips and sprays, flea collars, and wormers.

• Muscarinic signs include salivation, vomiting, diarrhea, bronchial secretion, miosis, and bradycardia.

• Nicotinic signs may be delayed in onset and include muscle tremors, neuromuscular weakness, exercise intolerance, and respiratory paralysis.

• CNS stimulation results in hyperactivity and seizures. • Organophosphate toxicity in cats is characterized by pronounced muscle weakness, mydriasis, twitching, and anorexia, which may last for weeks.

Exposure history, clinical signs, and low whole-blood cholinesterase activity (less than 25% of normal) suggest toxicosis.

• Induce vomiting if ingestion has occurred within 2 hours of presentation and the patient is asymptomatic. Provide a meal prior to giving an emetic. Follow with activated charcoal and a cathartic (may need to repeat every 8 hours).

• Bathe the animal in dishwashing detergent and water if exposure was by skin contact.

• Start anticonvulsants (IV diazepam, phenobarbital) if seizures occur (see Chapter 127).

• Administer 0.2 mg/kg atropine (0.05 mg/kg IV, 0.15 mg/kg SC); repeat as necessary for bradycardia, bronchoconstriction, respiratory depression, and other muscarinic signs.

• Use pralidoxime chloride (10-15 mg/kg IM or SC)

for muscle tremors and nicotinic signs.

• Intravenous fluids, nutritional support, frequent turns, and padded bedding are recommended.

The prognosis is good with early treatment.

Ivermectin is an avermectin used as an anthelmintic in large and small animals. The blood-brain barrier of normal animals normally prevents ivermectin entry into CNS tissues. A P-glycoprotein pump in brain endothelial cells transports any ivermectin that enters the CNS back into the systemic circulation. A subpopulation of collies, Shetland sheepdogs, Australian shepherds, and Old English sheepdogs are homozygous recessive for a specific P-glycoprotein gene mutation that results in a nonfunctional P-glycoprotein molecule. Ivermectin and other P-glycoprotein substrates are able to freely enter the brain of these affected individuals. Single oral doses of 100 to 500 mg/kg of ivermectin can be neurotoxic in these breeds.

• Ivermectin has inhibitory actions in the brain similar to GABA.

• Signs of neurotoxicity include ataxia, muscle tremors, symmetrical or asymmetrical tetraparesis, dullness, and sometimes coma.

• The more rapid the onset and progression of clinical signs, the more likely that signs will progress to coma.

• Mydriasis and apparent blindness have also been reported.

Ivermectin exposure and compatible clinical signs in a breed with known sensitivity to ivermectin is strongly suggestive of ivermectin neurotoxicosis.

Treatment is supportive only (there is no definitive way to remove the neurotoxin). Use fluid therapy, parenteral or enteral nutrition, turns, bladder and fecal management, and other supportive care for the recumbent, nonresponsive patient.

The prognosis is good with appropriate supportive care, but recovery can take several weeks.

Metronidazole (Flagyl) toxicosis is seen in the dog and cat following oral dosages of 66 mg/kg/day for more than 7 days. The mechanism of toxicity is unknown. Lesions of the vestibular nuclei and Purkinje cells of the cerebellum are recognized.

• Severe ataxia, positional vertical or rotary nystagmus, opisthotonus, seizures, asymmetrical upper motor neuron tetraparesis, and spastic muscle tremors may be seen acutely.

• Affected animals may exhibit a crouched posture in the pelvic limbs that is accentuated during ambulation.

• Many animals are weakened and disoriented to the point that they are recumbent, non-ambulatory, and anorexic.

Drug exposure and compatible clinical signs are suggestive of the diagnosis. Tests for inflammatory, neoplastic, or other causes of multifocal CNS disease are negative.

Discontinuing the drug will result in gradual resolution of clinical signs over 1 to 2 weeks. Provide supportive care as necessary.

M Key Point Diazepam (0.5 mg/kg IV or PO every 8 hours) reduces mean recovery time to less than 24 hours in most cases of metronidazole toxicity.

The prognosis is good if the drug is withdrawn.

Bromethalin is a pelleted anticoagulant rodenticide that uncouples oxidative phosphorylation in CNS mitochondria. This results in a cellular ATP deficit, a sodium-potassium pump failure, and mild cerebral and spinal cord edema. Cats are more susceptible than dogs to the neurotoxic effects. Histopathologic lesions are mild, indicating a functional deficit at the cellular level.

• Acute hyperexcitability, muscle tremors, hyperthermia, running fits, and focal or generalized seizures may be seen in dogs. Thoracic limb rigidity, nystagmus, anisocoria, and depressed levels of consciousness are also part of the acute syndrome in dogs. Death occurs within 10 hours if the amount of bromethalin ingested is >5 mg/kg of body weight.

• Chronic signs (1-4 days after ingestion) in dogs include depression, pelvic limb ataxia, paresis, and hyperreflexia. This progresses to paraplegia and loss of deep pain. Cats exhibit very similar clinical signs 3 to 7 days after ingestion.

• Exposure history and appropriate clinical signs suggest bromethalin toxicity.

• Tissue chemical analysis is definitive but not widely available.

• Induce vomiting, perform gastric lavage, and administer activated charcoal if it is less than 2 hours after ingestion. Activated charcoal and a cathartic are recommended every 4 to 8 hours for at least four doses.

• Mannitol and dexamethasone do not appear to alleviate clinical signs.

• Control seizures with IV diazepam or phenobarbital (see Chapter 127).

• Provide supportive care; avoid overhydrating the patient with IV fluids.

• Monitor for 48 hours to evaluate for continued absorption or delayed onset signs.

The prognosis is poor once neurologic signs are seen.

Ethylene glycol is a potent neurotoxin that can cause marked CNS depression. See Chapter 77 for additional information.

Most developmental defects of the brain affect either the cerebrum or the cerebellum. Clinical signs are usually present at birth and are nonprogressive. Congenital hydrocephalus can worsen postnatally with a gradual or sudden exacerbation of clinical signs. Although the majority of congenital malformations have a suspected genetic basis, a small number of disorders are due to in utero viral or toxic insults.

Primary hydrocephalus is a congenital disorder characterized by a pathologic accumulation of CSF within the ventricular system of the brain. Congenital hydrocephalus is recognized in the Maltese terrier, Yorkshire terrier, Chihuahua, Manchester terrier, Pomeranian, toy poodle, Cairn terrier, Shih Tzu, English bulldog, Boston terrier, Pekinese, Lhasa apso, and other breeds. Decreased CSF absorption at arachnoid villi and occlusion of the mesencephalic aqueduct are potential causes, but frequently an underlying structural abnormality cannot be identified. Congenital hydrocephalus may also be associated with other nervous system anomalies, including caudal occipital malformation syndrome, cerebellar hypoplasia, and meningomyelocele.

• Signs are usually seen in dogs less than 1 year of age, but trauma may precipitate signs in older dogs.

• Altered consciousness, head pressing, dementia, behavior changes, seizures, visual deficits, and ataxia are observed.

• Acute intraventricular hemorrhage can cause a sudden deterioration in neurologic status.

• Affected animals are frequently stunted, unthrifty, and poor doers.

• Associated signs are an open fontanelle, a thinned and domed calvarium, and a bilateral ventrolateral strabismus ("setting sun sign").

• Differential diagnoses include hepatic encephalopathy due to a portosystemic shunt, encephalitis due to infectious or idiopathic causes, and toxin exposure (lead).

• Skull radiographs may demonstrate a large, thinned calvarium with loss of gyral markings.

• Ultrasonography through an open fontanelle allows visualization of dilated ventricles.

• Optimal visualization of ventricular dilatation and subcortical white matter atrophy is obtained by CT or MRI. There may be mild to moderate asymmetry in ventricular size.

M Key Point The presence of acute to subacute forebrain signs in conjunction with marked ventricular dilatation is strongly suggestive of hydrocephalus.

• Affected animals have normal (normotensive) or elevated (hypertensive) CSF pressures.

• Provide therapy only if the patient has clinical signs of cerebral dysfunction. Many animals with ventriculomegaly are clinically normal and do not require therapy.

• Corticosteroids with or without furosemide benefit many patients in the short term.

• Mannitol is helpful if patients are exhibiting signs of acute ICP elevation.

• Anticonvulsant therapy is used for seizures (see Chapter 127).

Ventriculoperitoneal or ventriculovenous shunts can be placed to promote drainage of CSF. This procedure has alleviated clinical signs in some cases; however, referral to a neurosurgery specialist is required.

The prognosis is fair with early diagnosis and treatment.

Lissencephaly is a migration defect of neural cell precursors in the telencephalon characterized by an absence of cerebrocortical convolutions, thickened cortical gray matter, and thinned cortical white matter. It is presumed to be an inherited defect in the Lhasa apso, wirehaired fox terrier, and Irish setter. Affected wirehaired fox terriers and Irish setters often have concurrent cerebellar hypoplasia.

• Neurologic signs are usually present at birth or within the first year of life.

• Behavioral changes, visual deficits, dementia, and seizures are seen.

• Differential diagnoses are the same as for hydrocephalus (see above).

• CT or MRI reveals absence of gyri and sulci, thickening of the gray matter, and thinning of the white matter. Ventricular size is usually normal.

• There is no specific treatment for this condition. • Treat seizures symptomatically with anticonvulsants (see Chapter 127).

The prognosis is fair to poor. Seizures may be refractory to therapy.

• Congenital arachnoid cysts, also called subarachnoid cysts, are developmental anomalies characterized by cystic accumulation of fluid in the subarachnoid space. The cyst wall is composed of several layers of arachnoid cells.

• Arachnoid cysts can occur at any location along the neuraxis including the brain. Intracranial arachnoid cysts most frequently form between the cerebellum and the tentorium cerebelli and often are associated with the quadrigeminal cistern.

• Over time, the cyst can slowly enlarge to compress adjacent neural tissue.

• Signs are usually seen in young adults. • Seizures, paresis, abnormal behavior, and cranial nerve deficits may be observed. If the cyst is causing secondary hydrocephalus, diffuse forebrain signs may be evident.

• Arachnoid cysts may be incidental findings associated with no clinical signs.

• MRI or CT will reveal a well-circumscribed cystic structure compressing underlying brain tissue.

• Secondary hydrocephalus may be present if the cyst is compressing CSF outflow pathways.

Surgical fenestration of the cyst wall and partial excision will result in decompression of underlying neural tissues and prevent further damage to these tissues. Medical therapy with glucocorticoids and diuretics can be attempted but is usually only effective in the short term.

The prognosis is good if surgery is performed before significant irreversible brain atrophy has occurred.

Cerebellar hypoplasia refers to a defect in cerebellar development leading to decreased neuronal numbers with or without a gross reduction in size. This condition in kittens is usually due to an in utero or early postnatal panleukopenia viral infection (see Chapter 14). Vaccination of pregnant queens with modified live panleukopenia virus vaccine may also produce this syndrome. Rapidly dividing cells in the developing cerebellum are killed by the virus.

M Key Point Severe ataxia, falling, hypermetria, head intention tremor, head bobbing, and loss of menace response are usually seen at 3 to 4 weeks of age when kittens begin to ambulate.

• Signs are nonprogressive. • There may be fewer clinical signs with lesser degrees of cerebellar damage.

• Littermates may or may not be affected.

• Differential diagnoses are other infectious causes of cerebellar disease, cerebellar abiotrophy, or lysosomal storage disease.

• Clinical signs of a nonprogressive, purely cerebellar disorder in kittens are strongly suggestive of a diagnosis of cerebellar hypoplasia.

• CT or MRI will often reveal a small cerebellum.

No treatment is available.

The prognosis is poor for clinical improvement. Many cats with cerebellar hypoplasia make functional pets.

Most of the canine forms of cerebellar hypoplasia have a genetic basis. An exception to this is cerebellar hypoplasia secondary to postnatal herpesvirus infection. Breeds affected include the chow chow, Airedale, Irish setter, wirehaired fox terrier, Boston terrier, bull terrier, Weimaraner, dachshund, and Labrador retriever. The Irish setter and wirehaired fox terrier have concomitant lissencephaly. Selective involvement of the cerebellar vermis (vermian hypoplasia) is observed in the Boston terrier and bull terrier.

• Nonprogressive cerebellar signs are obvious at the time of ambulation, but subtle deficits can be detected from birth.

• Truncal ataxia, disequilibrium, dysmetria, falling, intention tremor, and an absent menace response are seen to varying degrees.

No treatment is available.

Strength, CP, and personality are maintained. If coordination is not incapacitating, affected dogs can make acceptable pets.

Inborn errors of metabolism can lead to neural cell degeneration after normal differentiation and maturation. Neuronal or glial cell degeneration is termed abiotrophy. A metabolic defect has not been identified in the vast majority of abiotrophies in animals. Neurodegenerative changes may occur within either the cell body or its processes. Although most abiotrophies affect the cerebellum, others may affect neurons in multiple brain regions. Neurodegenerative changes also occur with aging in some dogs and cats. Neuronal and glial changes are most severe in the cerebrum of older animals with this disorder.

Lysosomal storage diseases are autosomal recessive neurodegenerative disorders in which the cellular defect has been identified in most cases. Homozygous recessive individuals often exhibit a specific lysosomal hydrolase defect that leads to a cascade of structural and biochemical changes at the cellular level. The most obvious change is the accumulation of undegraded material within lysosomes, giving neurons a foamy, vacuolated, and swollen appearance. Other abnormalities include neuroaxonal dystrophy (axonal swellings), changes in synaptic connections, neurotransmitter and calcium imbalances, and occasionally cell death. Neuronal ceroid lipofuscinosis is unique in that massive neuronal cell loss and atrophy occurs in both the cerebrum and the cerebellum. Other lysosomal storage diseases do not share this feature.

M Key Point Animals affected with lysosomal storage disorders are normal at birth and weaning, but at a few months of age they develop a slowly progressive neurologic disease with multifocal cerebellar, brain stem, and spinal cord signs.

For reasons poorly understood, the cerebellum is especially vulnerable and will often show the most severe pathologic changes early in the disease course. Consequently, early clinical signs in the majority of lysosomal storage diseases are predominantly cerebellar in origin. Differential diagnoses for cerebellar signs in young cats and dogs include infectious diseases (FIP, cryptococcosis, toxoplasmosis, CDV, etc.), cerebellar hypoplasia, or cerebellar abiotrophy. With the exception of globoid cell leukodystrophy, lysosomal storage diseases are also characterized by visceral storage of undegraded material. Storage in liver, pancreas, spleen, kidney, bone marrow, adrenal glands, ocular structures, and lymph nodes is commonly found but rarely causes organ dysfunction. Globoid cell leukodystrophy results in storage within cells of the nervous system only and eventually produces central and peripheral demyelination.

Cerebellar abiotrophies have been identified in many canine breeds and in the cat. Breeds affected include the beagle, Samoyed, Irish setter, Kerry blue terrier, Gordon setter, American Staffordshire terrier, roughcoated collie, Airedale, Finnish harrier, Bern running dog, Bernese mountain dog, Labrador and golden retrievers, cocker spaniel, Cairn terrier, Great Dane, Australian kelpie, Brittany spaniel, English springer spaniel, bull terrier, and German shepherd. Normal cerebellar formation is followed by premature degeneration and cell death. Cerebellar Purkinje and granule cell loss usually occurs. Pathogenic mechanisms are largely unknown. An autosomal recessive mode of inheritance is proven in some breeds.

• Age of onset is usually between 4 and 10 weeks, but some breeds show an earlier or later onset. Most dogs are normal at birth.

• Progression may be slow or rapid. • Cerebellar signs of intention tremor and progressive ataxia and dysmetria are characteristic.

• Other causes of progressive cerebellar disease in young dogs (infectious diseases, lysosomal storage disease, myelin disorder, medulloblastoma) should be ruled out.

• CT or MRI may reveal a smaller-than-normal cerebellum, but usually the cerebellum is normal in size.

No treatment is available.

The prognosis is guarded to poor due to the progressive, debilitating nature of these disorders.

Multisystem neuronal abiotrophies are characterized by overt cell loss or chromatolytic change in multiple brain compartments. Breeds affected include the Kerry blue terrier, rough-coated collie, miniature poodle, cocker spaniel, and Cairn terrier. The primary lesion in Kerry blue terriers, rough-coated collies, and miniature poodles is cerebellar abiotrophy, but multiple brain stem nuclei, spinal cord neurons, and cerebrocortical neurons also degenerate. Affected cocker spaniels have cell loss in multiple regions and neuroaxonal dystrophy in cerebellar and cerebral white matter. Multisystem chromatolytic degeneration in Cairn terriers is characterized by chromatolysis of neurons in spinal cord, brain stem, and cerebellum. An autosomal recessive mode of inheritance has been demonstrated in some breeds.

• Onset of signs is between 4 and 16 weeks of age, and clinical progression may be rapid (over weeks) or slow (over months).

• Kerry blue terriers and rough-coated collies exhibit primarily cerebellar signs.

• Miniature poodles have early cerebellovestibular signs from 3 to 4 weeks of age followed by upper motor neuron tetraplegia at 4 months of age.

• Cocker spaniels show both cerebellar and cerebral signs at 1 year of age.

• Signs in Cairn terriers include cerebellar ataxia, paresis, and cataplexy.

• Differential diagnoses include lysosomal storage disease and inflammatory CNS disease.

• A tentative diagnosis is based on signalment, clinical signs, and progression.

• A definitive diagnosis can only be made postmortem.

No treatments are available.

The prognosis is poor.

Primary neuroaxonal dystrophy refers to an inherited error of metabolism resulting in swellings or spheroids along any region of the axon. The distal axon and axon terminal are the most common cellular sites affected by this neurodegenerative disease. Any region of the CNS may be affected, including the cerebellum, cerebrum, and brain stem. Neuroaxonal dystrophy has been reported in the rottweiler, Jack Russell terrier, Chihuahua, collie-sheepdog mixed breed, bullmastiff, Labrador retriever, and domestic shorthaired cat. An autosomal recessive mode of inheritance is known or suspected in these breeds.

• Clinical signs are primarily cerebellar in origin in the majority of affected breeds.

• Cerebral signs are seen in the Labrador retriever.

• Differential diagnoses include inflammatory, metabolic, toxic, and other congenital causes of cerebellar or cerebral disease.

• No specific diagnostic tests are available.

No treatment is available.

See Table 126 -5 for information about the more important lysosomal storage disorders.

• Canine cognitive dysfunction is a neurodegenerative disease of the forebrain characterized by a very gradual onset and progression of cognitive decline in dogs greater than 11 years of age.

• The cause of cognitive dysfunction is not fully understood, but certain morphologic and functional changes are recognized in association with this syndrome.

• Cortical atrophy due to neuronal loss (apoptotic cell death), amyloid plaques and perivascular amyloid, myelin degeneration with perivascular macrophage infiltration and gliosis, and intraneuronal lipofuscin accumulation are commonly observed. Changes in the frontal and temporal lobes are most severe. The density of amyloid plaques shows a correlation with the severity of cognitive decline.

• Functional changes hypothesized to occur include decreased levels of norepinephrine and dopamine in frontal cortex, increased monoamine oxidase activity with increased norepinephrine and dopamine breakdown (with free radical formation), alterations in post-synaptic receptor numbers and function, and decreased mitochondrial energy production.

M Key Point The clinical course of canine cognitive dysfunction is often 18 to 24 months or longer. Behavior problems are "newly emergent" and should not resemble previous behavior patterns in the pet.

Behavior changes include decreased spatial orientation (staring, wandering, getting lost, resisting confinement), decreased responsiveness and social interaction (no seeking of affection, loss of owner recognition, resistance to handling), loss of house training, and altered sleep-wake cycles (active at night and sleeping during the day).

• A tentative diagnosis can be made based on a compatible history and clinical signs and by ruling out disorders that may mimic the signs of cognitive dysfunction.

• The neurologic examination is normal with the exception of abnormalities of mentation that include resisting restraint, agitation, increased startle, blank stare or shifting eye movements, and aimless pacing and wandering. Lateralizing deficits and seizures are not observed.

• Affected dogs should be screened for concurrent disorders such as vision and/or hearing loss and for metabolic and endocrine imbalances that may impact normal brain function.

• MRI or CT will rule out a brain tumor or vascular lesion as the cause of the dementia. Corticocerebral atrophy with secondary ventriculomegaly is a common finding.

• Cognitive dysfunction secondary to neurodegeneration is not a traditional behavior disorder. Since manifestations of dementia are due to a neurodegenerative process, behavior modification strategies are usually not effective.

• Steps that modify the pet's environment, such as providing adequate space and footing, building ramps, and fencing outdoor areas, are useful. Frequent attention, close monitoring of nutrition, and "timed" feeding and exercising are also advised.

• Medical therapy that has been approved for use with this disorder is selegiline. Improved sleep-wake cycles, activity levels, and house training have been reported after administration of 0.5 to 1.0 mg/kg PO every 24 hours (given in the morning). Selegiline inhibits the breakdown of several monoamines, including dopamine, norepinephrine, and 2phenylethylamine, and facilitates dopaminergic transmission and activity. This condition can be managed but not cured. Response to medical therapy is variable. Neurodegenerative changes will continue, and response to therapy is often transient at best.

Disorders of the peripheral portions of cranial nerves may occur secondary to neoplastic, inflammatory, idiopathic, congenital, and endocrine diseases. The most common cranial neuropathies affecting CN5, CN7, or CN8 are discussed below. Horner's syndrome is dis-cussed in Chapter 141. Laryngeal paralysis is covered in Chapter 161. Megaesophagus is discussed in Chapter 65.

The etiology is unknown. A bilateral, nonsuppurative neuritis of CN5 and its ganglia is seen histologically. There is no breed predilection. Most dogs are middle aged. • An acute to peracute onset of a dropped jaw and inability to close the mouth are seen. The signs are nonprogressive and muscle atrophy rarely occurs.

• Animals have difficulty prehending and chewing food. Food and water fall out the sides of the mouth. Swallowing abilities are usually maintained if food is placed in the back of the mouth.

• A unilateral or bilateral Horner's syndrome may be seen in association with trigeminal neuritis.

• Sensation to the face is usually normal, and there are no long tract signs or changes in mentation.

• Pain may be elicited upon palpation around the jaw.

• Acute, severe mandibular paralysis in the absence of other neurologic deficits is usually pathognomonic for this disease.

• Lymphoma and other myelomonocytic leukemias with nerve root involvement may rarely produce similar signs.

• Therapy is strictly supportive. Maintaining hydration and nutrition is critical.

• Corticosteroid therapy is of no benefit.

M Key Point Idiopathic trigeminal neuritis is a selflimiting disorder with recovery taking place within 2 to 4 weeks after the onset of signs. The prognosis is excellent with adequate nutritional support.

An idiopathic paralysis of the facial nerve occurs in dogs. There may be unilateral or bilateral involvement. Histologically, there is axonal degeneration with secondary demyelination of the facial nerve. There appears to be a high incidence in cocker spaniels.

• Signs are acute in onset and nonprogressive. • Complete paralysis of the facial nerve results in a unilateral facial droop (lips, ears, etc.) and an inability to blink the eye. The palpebral fissure may be wider than normal.

• Food, water, and saliva tend to fall out the side of the mouth that is paralyzed.

• In the acute stage, the nasal philtrum is deviated slightly toward the unaffected side due to unopposed nasal muscles.

• Denervation of the lacrimal gland may lead to decreased tear production.

• Facial contracture (lip retraction, deviation of the lip and nose toward the affected side) can be seen chronically.

• No other neurologic signs are usually present, but involvement of the opposite facial nerve is not uncommon.

Differential diagnoses include otitis media or interna (see Chapter 61), hypothyroid neuropathy (see this section and Chapter 31), a neuropathy associated with pituitary lesions, lead poisoning, neoplasia, and trauma.

There is no treatment. Artificial tears may be needed to prevent corneal lesions (see Chapter 139).

The prognosis for recovery of function is guarded to fair. Many dogs may recover partial function only.

Etiology This is a disease of older dogs (average age of 12-13 years) of any breed. The pathogenesis is unknown. This condition can also occur in the cat at any age, but it usually occurs in young adult cats.

• Signs of vestibular imbalance are peracute and include head tilt, ataxia, circling, falling, rolling, and nystagmus (usually rotary) with a fast phase away from the side of the head tilt.

• Affected dogs are disoriented and frequently agitated.

• Postural reactions and strength are preserved, and there are no other cranial nerve deficits.

• Anorexia with or without vomiting is common. • Signs are most severe at the onset and gradually improve over days to weeks.

• Otitis media or interna, hypothyroidism, trauma, vascular disease, and neoplasia are differential diagnoses.

• Otic examination, bulla radiographs or CT, thyroid testing, blood pressure measurement, and other screening tests for vascular disease may be performed to exclude the above differential diagnoses.

• There is no specific treatment. • Steroid therapy is not beneficial.

• Nutritional and fluid support may be necessary if persistent nausea and anorexia are present.

• A padded, confined area may be needed to prevent self-injury.

M Key Point The prognosis is good to excellent for recovery in dogs with idiopathic vestibular disease. Improvement is usually seen over the first 2 to 3 days after onset, and resolution of the majority of signs is observed 10 to 14 days after onset. Recurrences can occur but are uncommon.

Thyroid hormone deficiency can cause an unusual combination of peripheral and central vestibular signs.

Other cranial nerves may be affected, especially CN7 and CN10 and the sensory branches of CN5.

• Middle-aged to older dogs of any breed may be affected, and there may be no other signs of hypothyroidism.

• The onset may be rapid or chronic and the clinical course may be static or progressive.

• Vestibular signs are usually unilateral (head tilt, etc.) but signs can be bilateral. The character of the nystagmus is vertical, horizontal, rotary, or direction changing. Vestibular ataxia is usually present with listing and falling toward one side.

• Differential diagnoses include otitis interna, idiopathic vestibular disease, vascular disease, infectious disease, or neoplasia.

• Otoscopic exam, CSF analysis, and imaging studies (CT or MRI) are typically normal.

• A complete thyroid panel is necessary to distinguish non-thyroidal illness from true hypothyroidism (see Chapter 31).

Treatment is thyroid supplementation (see Chapter 31). Resolution of signs can occur but is gradual over 1 to 4 months.

The prognosis is good for eventual return of vestibular function.

The most common tumor that may involve CN5 is the neurofibroma or schwannoma. Lymphoma and meningioma may involve the trigeminal nerve less commonly. Trigeminal neurofibromas are invariably unilateral and usually originate peripherally with eventual encroachment on brain stem structures in the region of the cerebellopontomedullary angle. Nuclei of CN7 and CN8 may secondarily be affected. This neoplastic disease occurs in middle-aged to old dogs.

• The onset and progression of signs are slow (over months).

• Marked unilateral temporalis and masseter muscle atrophy is seen initially.

• Jaw weakness is not clinically apparent. • Muscle atrophy is followed by facial sensory loss. • Brain stem involvement is indicated by the onset of ipsilateral vestibular signs, facial muscle weakness, and occasionally long tract signs with ipsilateral hemiparesis and conscious proprioceptive deficits.

• The main differential diagnosis is trauma to CN5.

The progressive course of this disorder helps rule out trauma.

• Electromyography and temporal muscle biopsies reveal signs of denervation.

• Contrast-enhanced MRI scanning is most sensitive in detecting the tumor location and extent.

• Surgical excision is the treatment of choice, but the surgery is technically demanding and rarely achieves complete excision.

• Radiation therapy appears to slow progression of the tumor, but further clinical studies are needed to confirm this observation.

• MRI aids surgical and radiation planning and may improve outcome.

The prognosis is guarded to poor, especially if brain stem involvement has occurred.

Primary neurofibromas of CN8 are rare. Meningiomas in the caudal fossa may affect the extradural, intra-cranial portion of CN8. Secondary tumors affecting CN8 usually originate in the temporal bone or bullae and invade the nerve or its peripheral receptors by local extension. Squamous cell carcinoma, ceruminous gland adenocarcinoma, osteosarcoma, and chondrosarcoma are tumors in this category and do occur in the dog and cat. Middle ear polyps in cats may also secondarily involve vestibular and cochlear structures in the inner ear (see Chapters 61 and 62).

• Slowly or rapidly progressive vestibular signs are observed.

• Horner's syndrome and other cranial neuropathies (especially of the facial nerve) may be seen concurrently.

• Rule out otitis media and interna (see Chapter 61), idiopathic conditions, and endocrine-related neuropathy.

• Otic examination and biopsy may reveal a neoplastic process.

• Bullae radiographs detect soft tissue opacities or bony lysis.

• CT is useful in identifying both bony and neural parenchyma involvement.

• MRI is the imaging modality of choice for determining the extent of neural parenchymal involvement.

Total surgical resection is usually not possible, except in the case of a benign inflammatory polyp.

The prognosis is usually poor.

Postnatal cochlear hair cell and spiral ganglion degeneration occurs in many breeds, including dalmatians, English setters, bull terriers, Old English sheepdogs, English bulldogs, Australian heelers, border collies, collies, Australian shepherds, Australian cattle dogs, Catahoulas, Norwegian dunkerhounds, pointers, rottweilers, and white cats with blue irises. Cochlear structures develop normally, but degeneration of the stria vascularis is soon followed by loss of cochlear hair cells. The pathogenesis is unknown. The method of genetic transmission is also poorly understood in most breeds.

• Owners may not recognize a deaf puppy for several months.

• Poor response to verbal commands and loud noises often indicates bilateral deafness.

• Unilaterally deaf pups may not orient to sounds properly or may appear completely normal.

• Clinical signs may or may not be definitive.

• The BAER will accurately detect unilaterally and bilaterally deaf animals.

There is no treatment for this degenerative disorder.

The prognosis is poor for recovery of hearing. Special behavioral training is often necessary for dogs with bilateral deafness.

Central nervous system

Age-related changes in the brain of the dog

deLahunta A: Veterinary Neuroanatomy and Clinical Neurology

A Practical Guide to Canine and Feline Neurology

Central nervous system toxicosis associated with metronidazole treatment in dogs: Five cases

Diseases of the brain

Management of organophosphate and carbamate insecticide toxicoses

Tumors of the nervous system

Degenerative brain disease

Kirk's Current Veterinary Therapy XI: Small Animal Practice

Veterinary Neuropathology

Nonneoplastic disorders of the brain